Details for New Drug Application (NDA): 211240
✉ Email this page to a colleague
The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 211240
Tradename: | CLOBETASOL PROPIONATE |
Applicant: | Quagen |
Ingredient: | clobetasol propionate |
Patents: | 0 |
Pharmacology for NDA: 211240
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 211240
Suppliers and Packaging for NDA: 211240
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLOBETASOL PROPIONATE | clobetasol propionate | SOLUTION;TOPICAL | 211240 | ANDA | Quagen Pharmaceuticals LLC | 70752-153 | 70752-153-04 | 1 BOTTLE in 1 CARTON (70752-153-04) / 50 mL in 1 BOTTLE |
CLOBETASOL PROPIONATE | clobetasol propionate | SOLUTION;TOPICAL | 211240 | ANDA | Quagen Pharmaceuticals LLC | 70752-153 | 70752-153-20 | 1 BOTTLE in 1 CARTON (70752-153-20) / 25 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | 0.05% | ||||
Approval Date: | Feb 17, 2022 | TE: | AT | RLD: | No |
Complete Access Available with Subscription